Marshall Wace, LLP Evolent Health, Inc. Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Evolent Health, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 654,747 shares of EVH stock, worth $2.74 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
654,747
Previous 26,779
2345.0%
Holding current value
$2.74 Million
Previous $301,000
1740.2%
% of portfolio
0.01%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding EVH
# of Institutions
276Shares Held
130MCall Options Held
323KPut Options Held
211K-
Cadian Capital Management, LP New York, NY11.7MShares$49 Million5.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA11MShares$45.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.69MShares$36.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.98MShares$33.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.29MShares$26.3 Million0.98% of portfolio
About Evolent Health, Inc.
- Ticker EVH
- Exchange NYSE
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 97,063,696
- Market Cap $406M
- Description
- Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...